Physicians Office Resource - January 2021 by Physicians Office Resource

Physicians office Resource

2021 | Issue 1

Resources for You, Your Patients, & Your Practice

HELPING YOU HIT THE MARK IN FLU TESTING The Acucy® Influenza A&B Test on the Acucy® System provides clinicians flexibility in workflow and accurate, standardized results for improved patient care.

PAGE 4

CORONAVIRUS LABORATORY TESTING

THE ROLE OF VITAMIN D IN THE COVID-19 PANDEMIC

PLANNING FOR NEW INSTRUMENTS/NEW TESTS

PUBLISHED BY Medical Education Resources, LLC PUBLISHER Aaron R. Medaris amedaris@physiciansofficeresource.com

CEO Andrew C. Nimmo acnimmo@physiciansofficeresource.com

PRESIDENT John D. Pasquale jpasquale@pharmaconnect.com

Getting the most from this guide

BUSINESS MANAGER Marci J. Hills mhills@physiciansofficeresource.com

TRAVEL EDITOR Brandi L. Brower EDITORIAL BOARD Michael Paquin, FHIMSS Barry Craig, MLT (NCA), CLC STAFF WRITER Dylan J. Chadwick

There are two simple ways to request

CREATIVE DIRECTOR PRODUCTION MANAGER Jessica Peterson

information about the products and services

found in Physicians Office Resource. 1. Go to www.PhysiciansOfficeResource.com and enter the four-digit reference number found next to the product or service into the search field, then request additional information, schedule a demo, or speak with a sales agent all with just a simple click of a button. 2. Find the Business Reply Card in this issue, circle the desired reference numbers, complete the form, and drop into any USPS mailbox. A representative will contact you as quickly as possible to answer your questions.

www.PhysiciansOfficeResource.com

2 | PHYSICIANS OFFICE RESOURCE

To continue your free subscription of Physicians Office Resource magazine, please fill out the Business Reply Card (BRC) located within this magazine and drop in any United States Post Office mailbox. If you are a manufacturer of medical products or provide services to medical professionals and would like to advertise your products or services to the nation’s top physicians doing in-office testing, call 801-380-6094 or visit: POR.io for more information.

Let us help you make COVID-19 testing and daily compliant reporting to state and federal agencies easy!

Point-of-Care Testing

Physician Office Laboratories

Urgent Care & Emergency Centers

Pain Management Laboratories

Cost-effective, Easy to Use Lab Data Management and Compliance Software Solutions POC to High Complexity Testing manage patient lab test orders to completed results • Automatically Connect to EHR - post results to patient chart • Document lab compliance requirements - QC and patient results all in one place • Instruments of Choice

Medicus POC LIS

8970

EHR

COVID-19

Hematology

Flu/Strep/RSV

Chemistry

Glucose

Urinalysis

PT/INR

Link Your Lab For more information, please call 888.643.8081 or email sales@medicuslis.com

medicuslis.com

TABLE OF CONTENTS

8900

HELPING YOU HIT THE MARK IN FLU TESTING The Acucy ® Influenza A&B Test is for the rapid, qualitative detection of influenza A and B viral nucleoprotein antigens from both nasal and nasopharyngeal swabs. Utilizing the Acucy ® Reader in either the point-of-care or laboratory setting, workflow flexibility is achieved with both Read Now and Walk Away features. The combination provides clinicians with standardized and definitive result interpretation.

CORONAVIRUS LABORATORY TESTING

THE ROLE OF VITAMIN D IN THE COVID-19 PANDEMIC

PLANNING FOR NEW INSTRUMENTS/NEW TESTS

— After successful genetic sequencing and characterization of the SARSCoV-2 virus, instrument manufacturers raced to develop laboratory tests for the detection of SARS-CoV-2. Widespread testing of the population is essential to mitigate the spread of the virus through quarantining and contact tracing.

4 | PHYSICIANS OFFICE RESOURCE

— Potential treatments were being investigated daily, including research of common vitamin sufficiency. Vitamin C and Zinc have long been known to boost immune system health, which could help against this respiratory illness.

— Whether planning a new, start-up laboratory operation, or performing an analysis of current testing, (providing input for decisions on whether or not to purchase new or replacement instruments, or add or delete tests), it is important to do a realistic assessment not only of what you want to offer your ordering physicians, but what you can realistically offer.

GET BETTER OUTCOMES WITH CRYOSURGERY

NEW FOR

8902

2021!

Your choice of a cryosurgical device has a big impact on patient outcomes. CryoConcepts has the broadest line of cryosurgical equipment in the world and our 28 years of experience is built into every single product.

BETTER DESIGN. BETTER OUTCOMES. BETTER FOR THE ENVIRONMENT. Our world class products include: CryOmega®, a portable pen-like device, CryoLab® Medical, a desktop-sized cryo unit, and Histofreezer® FLEX, our next generation canister that uses both cones and buds AND has the first returnable canister that is better for the environment.

8901

MAR-115 (Rev 1)

Scan QR code for: ❆ A Virtual or In-Office Demo of any of our products

All Things

CRYO

❆ A FREE Lunch & Learn with our nationwide team of Cryo Experts

www.CryoConcepts.com

❆ A FREE E-book on better outcomes using cryosurgery in your practice

FEATURE

CORONAVIRUS LABORATORY TESTING: Which Methodology is Right for Your Practice and Your Patients? BY MARC SEAMAN, PH.D

Itâ€™s been a year since reports of SARS-CoV-2, the coronavirus that causes COVID-19, emerged in the United States. After successful genetic sequencing and characterization of the SARS-CoV-2 virus, instrument manufacturers raced to develop laboratory tests for the detection of SARS-CoV-2. Widespread testing of the population is essential to mitigate the spread of the virus through quarantining and contact tracing. As of December 2020, the Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to over 250 tests in the three main test classes â€“ Molecular/Reverse Transcriptase Polymerase Chain Reaction (RT-PCR), rapid antigen and antibody testing. The first two tests detect active disease and the third detects evidence of past infection. Additionally, there are significant differences 6 | PHYSICIANS OFFICE RESOURCE

between each class of test in terms of suggested timing from onset of symptoms, specimen collection route, time to results, cost, specificity, and sensitivity. In this article, we will give a brief overview of the science and technology behind each class of tests and how the technology and science inform the selection of the proper test to administer to identify SARSCoV-2 infection in the patient population. Nearly all molecular laboratory instrument manufacturers have developed and received EUA for RT-PCR SARS-CoV-2 tests. Coronavirus RT-PCR test specimens are typically collected via swab in the nasopharynx, nasal cavity or throat; saliva is a less common specimen collected for Coronavirus RT-PCR testing. PCR uses DNA, double-stranded genetic code, as a template to amplify and generate detectable levels

FEATURE

of DNA from miniscule, non-detectable levels on a specimen swab. Using extremely specific reagents called primers, PCR replicates template DNA to make exact copies of the template DNA. This process is repeated 20-30 times and because each new copy serves as the template for another copy in the next cycle, the amount of DNA doubles and increases exponentially with every cycle. After 20-30 cycles, previously undetectable genetic material is now detectable. DNA is detected via fluorescent signal produced by fluorescent dyes that bind DNA. Coronaviruses do not use double stranded DNA for their genetic code, instead they use single stranded RNA. In order to convert single stranded RNA to double-stranded so that PCR amplification can occur, reverse transcription is needed. Once RNA is converted to a double-stranded DNA-

like template, PCR can proceed to generate detectable levels of Coronavirus genetic material to diagnose infection. Due to the amplification of specific genetic material, PCR has exquisite sensitivity and specificity, meaning false-negatives and false-positives are rare; these are good traits of a diagnostic screening test. Specimen processing and preparation and PCR analysis can typically be completed in 4 to 6 hours, so results can be available to the patient on the same day; however, laboratories are sometimes not able to turn around results same day due to instrument and operator availability, laboratory backlog and inefficiencies in reporting systems. As a result, turnaround times of up to one week are possible, if not common. Another test for active infection is antigen testing. Al2021, ISSUE 1 | 7

FEATURE

“…there are significant differences between each class of test in terms of suggested timing from onset of symptoms, specimen collection route, time to results, cost, specificity, and sensitivity.”

though not as common as RT-PCR for Coronavirus testing, many instrument manufacturers have received EUA for diagnostic SARS-CoV-2 antigen tests. The coronavirus is composed of lipid, RNA and protein molecules. Whereas RT-PCR detects viral RNA, antigen testing detects viral proteins. The nucleocapsid protein and spike protein on the outer coating are the main targeted proteins/antigens in antigen testing. Antigen test specimens are collected via swab from the nasopharynx and nasal cavity. Once collected the specimen is processed to disassociate the coronavirus into its lipid, RNA and protein components. The processed specimen is added to a lateral flow device and viral components are pulled through the device via capillary effect. The first section of the antigen testing device contains labeled (e.g. fluorescent) coronavirus specific antibodies and when the viral protein components contact these antibodies, a coronavirus protein-labeled antibody complex is created. Next, the coronavirus protein-labeled antibody complexes pass over a line of immobilized coronavirus specific antibodies that bind and immobilize the protein-labeled antibody complexes. Over time, the number of complexes accumulate on the immobilization line and the presence of coronavirus proteins can be detected. Viral components travel quickly through the lateral flow antigen testing device, usually in 5 to 30 minutes, therefore “rapid” is usually associated with antigen tests and results are available to the patient within the hour or at least on the same day. However, unlike in RT-PCR, viral antigens are not amplified, so antigen testing has comparatively less sensitivity. Because antibodies are very specific for coronavirus antigens, specificity of antigen testing is excellent. This means that the chance for false-negatives is increased in antigen testing compared to RT-PCR, but like RT-PCR, false-positive results are rare. The third class of testing, antibody testing, detects prior coronavirus infection. During infection, the body generates antibodies to the pathogen as part of the immune response. Antibodies are also called immunoglobulins and the two most common antibody isotypes found in blood are Immunoglobulin G (IgG) and Immunoglobulin M (IgM). IgG and IgM antibodies are detectable typically 1 to 3 weeks after symptom onset. IgM levels peak approximately a week after infection, whereas IgG production begins 1 week after symptom onset and peaks 3-4 weeks after symptom onset. Most antibody tests detect IgG and IgM simultaneously. Antibody tests utilize a number of technologies including: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Enzyme Immunoassays (CLIA), Chemiluminescent Microparticle Immunoassay (CMIA), Fluorescence Immu8 | PHYSICIANS OFFICE RESOURCE

noassays (FIA), and the Lateral Flow Immunoassays (LFIA). Although there are many antibody detection technologies, each detects the presence of patient generated antibodies against coronavirus in the same basic manner. For illustrative purposes, lateral flow antibody test technology will be described. First, the anti- coronavirus antibodies in a patient’s blood sample incubate with labeled manufactured coronavirus protein mimetics to form labeled protein-antibody complexes. Next, protein-antibody complexes pass over a line of immobilized antibodies that recognize either IgG or IgM (IgG and IgM specific to the Coronavirus? Or just any IgG/IgM floating in the serum?). If recognized, movement is halted and protein-antibody complexes accumulate on the line, generating a signal that can be detected. Like antigen testing, antibody testing can be completed quickly and results can be available to the patient on the same day of testing. In terms of sensitivity and specificity, antibody tests perform similar to antigen tests; they are less sensitive compared to RT-PCR, but all three testing methods have excellent specificity. In determining which platform is right for your testing needs, the factors presented in this article should be considered. If ease of testing and rapid time to results is desired, antigen testing would likely be a fit; however, the lack of sensitivity of antigen testing leads to the potential for more false-negatives. RT-PCR tests have the highest sensitivity, but results often take days or up to a week to become available to physicians and patients. If you’re interested in determining the extent of recent past coronavirus infection within your patient population, antibody testing is the best fit. — Marc Seaman, Ph.D, received a bachelor’s degree in Biomedical Engineering at the Georgia Institute of Technology and a doctoral degree in Biomedical Engineering from the University of Virginia. As an accomplished scientist with over a decade of experience in academic research and pharmaceutical contract research, Marc is now working within the medical device industry. As Director of Business Development for Medicus Laboratory Information Systems, Marc will continue his work in science, along with offering new ways to implement, document, manage and monitor patient data more efficiently. Helping labs help patients is a passion and strong career focus of Marc’s. With proven expertise in PCR technologies, Marc will now share innovative ways to offer the clinical and research laboratory environment excellent solutions for all testing disciplines including infectious disease testing and reporting.

Round up SARS-CoV-2 and 18 other pathogens. The new BioFire® Respiratory 2.1-EZ (RP2.1-EZ) Panel1 covers COVID-19 detection in your clinic. SARS-CoV-2 is everyone’s top suspect, but many other respiratory bugs can cause similar, overlapping symptoms. In your clinic, you can test for 19 common respiratory pathogens, including SARSCoV-2, with the BioFire RP2.1-EZ Panel—now available under an FDA Emergency Use Authorization.1.2 Syndromic testing means all it takes is one test and about 45 minutes to round up SARS-CoV-2—and all the other usual respiratory suspects. Rapid answers on a broad range of pathogens can inform patient management and alleviate patients and staff alike. What’s your frontline solution into respiratory season and beyond?

8903

1. This test has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by authorized laboratories. This test has been authorized only for the detection and differentiation of nucleic acid of SARS-CoV-2 from multiple respiratory viral and bacterial organisms. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. 2. For use with the CLIA-waived BioFire® FilmArray® 2.0 EZ configuration.

BFR0001-0517-01

To learn more, visit biofiredx.com

PRODUCT FOCUS

CHEMISTRY ANALYZERS EASY, INTEGRATED WITH-PATIENT TESTING I-STAT SYSTEM

Easy, Integrate i-STAT System

From Point of Care at Abbott

The handheld i-STAT System offers a broad menu of diagnostic tests at the patient’s side in just minutes. With just a few drops of blood, the i-STAT System delivers real time, lab-accurate results for a wide range of tests, including chemistries, blood gas, coagulation, cardiac markers, and more. Minimize delays and wasted time with on-side tests. Easy, intuitive operation. For intended use and complete product information, visit pointofcare.abbott.

The handheld i-S patient’s side in System delivers including chemis 8904 Minimize delays

For intended use an

For in vitro diagnostic use only. This material is intended for a U.S. audience only. i-STAT is a trademark of Abbott. Physician Office Resource i-STAT Product Description — US 3064.REV1 08/20

For in vitro diagnostic us i-STAT is a trademark of

View Brochures, Videos & More at POR.io Enter Number 8904 in the Search Area

FULL COMPLEMENT OF CLIA-WAIVED

Full Complement of CLIA-waived Blood Chemistry Tests BLOOD CHEMISTRY TESTS PICCOLO Piccolo Xpress® Chemistry Analyzer from Abbott

XPRESS® CHEMISTRY ANALYZER

The Piccolo From XpressAbbott Chemistry Analyzer provides physician offices with lab-accurateThe results for Xpress a broad range ofAnalyzer CLIA-waived general chemistry Piccolo Chemistry provides physician tests, including metabolic panels, lipids, kidney offices with lab-accurate resultsliver, for a and broad range function, of CLIA- and more general tests, panels, provides with just 100waived microliters of chemistry blood. Easy toincluding use, themetabolic Piccolo Xpress lipids, live, and kidney function, and more with just 100 a patient’s visit, accelerating treatment decisions, increasing 8905results during microliters of blood. Easy to use, the PIccolo Xpress provides efficiency, and supporting Automated quality control on results during apatient patient’ssatisfaction. visit, accelerating treatment decisions, increasing efficiency, and supporting patient satisfaction. every test helps ensure accuracy. Automated quality control on every test helps ensure accuracy.

For in vitro diagnostic use only. This material is intended for a U.S. audience only. Brochures, Videos &distributed More at POR.io Piccolo Xpress is aView registered trademark of Abaxis, Inc. and by Abbott Point of Care. Physician Office Resource Product8905 Description US 3065.REV1 Enter Piccolo Number in –the Search 08/20 Area

DRUGS OF ABUSE TESTING AND ROUTINE CHEMISTRY PANELS ON A SINGLE ANALYZER From Carolina Liquid Chemistries Carolina Liquid Chemistries Corp. announces the successful launch of Medica Corporation’s high-speed benchtop analyzer, the EasyRA®. The updated analyzer now operates at a photometric rate of up to 240 tests per hour or up to 480 tests per hour with ISE. The EasyRA urine drug screening and general chemistry reagents are CLIA categorized as moderately complex. This all-in-one system allows clinical laboratories to screen for drugs of abuse in urine while also allowing healthcare providers to assess routine chemistry panels on a single analyzer.

View Brochures, Videos & More at POR.io Enter Number 8906 in the Search Area

10 | PHYSICIANS OFFICE RESOURCE

8906

Stronger Clinical Performance Takes Lateral Flow Testing To The Next Level

Providing superior rapid results at the point-of-care. Fast, easy, cost effective so you can test and treat in one visit. High Performance Equivalent to or exceeding the performance of reader devices, without the need for an instrument

SENSITIVITY

SPECIFICITY

Results in 10 minutes OSOM® Custom Care Exceptional Support/Training by licensed medical technologists and experienced healthcare professionals Made in the USA Award-winning supply chain capabilities For more information call 888-616-0537, Option 2, or visit us at www.osomtests.com.

MADE IN THE USA

8907

ASSESSING AND MONITORING COVID-19 PATIENTS. Urgent care facilities, primary care practices, and other outpatient settings at the front lines of the COVID-19 pandemic need on-site testing solutions to support patient assessment and monitoring. With-patient testing can lead to better healthcare performance by facilitating decisions that can optimize patient outcomes in real time, improving the quality of patient care.

8908

For facilities treating COVID-19 patients, having rapid, accurate diagnostic test results may be useful when assessing or monitoring patients for: • C-Reactive Protein (CRP) Levels may be elevated in COVID-19 cases, especially severe cases.2-15 • Liver, Kidney and Cardiac function Elevated levels of the following biomarkers may be indicators of COVID-19 severity:16-27 - Alanine Aminotransferase (ALT)16,17,20-27 - Albumin (ALB)16,19-22,25-27 - Aspartate Aminotransferase (AST)16,17,19-21,23-26 - Creatine Kinase (CK)16,18,20,22-24 - Creatinine (CREAT)16,22,23,25,27 - Total Bilirubin (TBILI)16,20,25,27

ON-SITE TESTING MADE EASY: PICCOLO XPRESS.® The Piccolo Xpress portable diagnostic analyzer offers a full complement of blood chemistry tests, including CLIA-waived tests. Get accurate results in minutes, at the point-of-care. SEE A LIST OF KEY PICCOLO XPRESS PANELS ON BACK.

For in vitro diagnostic use only. The Piccolo Xpress does not directly diagnose COVID-19.

KEY PICCOLO XPRESS PANELS. CLIA-WAIVED PANELS

MODERATELY COMPLEX PANELS

Comprehensive Metabolic Panel

BioChemistry Panel Plus

Na+, K+, CI-, tCO2, Ca, BUN, Crea, Glu,

ALB, ALP, ALT, AMY, AST, BUN, Ca,

ALB, ALP, ALT, AST, TP, tBIL, eGFR*

Crea, Glu, GGT, TP, UA, CRP, eGFR*

MetLyte 8

MetLyte Plus CRP

Na+, K+, Cl-, tCO2, BUN, Crea, Glu,

CK, eGFR*

CK, CRP, eGFR*

Liver Panel Plus

Hepatic Function Panel

ALB, ALP, ALT, AMY, AST, GGT,

ALB, ALP, ALT, AST, tBIL, dBIL, TP

tBIL, TP

*Calculated

To learn how the Piccolo Xpress portable diagnostic analyzer can help transform your patient care, contact your Abbott Point of Care Representative or visit www.pointofcare.abbott 1.

2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14.

The Governing Board The American Association for the Study of Liver Diseases, Released: April 7, 2020. CLINICAL INSIGHTS FOR HEPATOLOGY AND LIVER TRANSPLANT PROVIDERS DURING THE COVID-19 PANDEMIC. Guan WJ et al. medRxiv preprint 2020; doi: https://doi.org/10. 1101/2020.02.06.20020974 Chen N et al. Lancet 2020; 395: 507–13 ; https://doi. org/10.1016/S0140-6736(20)30211-7 Cao W et al. medRxiv preprint 2020; doi: https://doi. org/10.1101/2020.02.23.20026963 Shi H et al. Lancet Infect Dis 2020 ; https://doi.org/10.1016/ S1473-3099(20)30086-4 Shi S et al. Jama Cardiology 2020; published online March 25; doi:10.1001/jamacardio.2020.0950 Xu H et al. medRxiv preprint 2020; doi: https://doi. org/10.1101/2020.03.05.20031591 Young BE et al. JAMA. Published online March 3, 2020; doi:10.1001/jama.2020.3204 Ruan Q et al. Intensive Care Medicine 2020. https://doi. org/10.1007/s00134-020-05991-x Zhou B. Research Square 2020; DOI:10.21203/rs.3.rs-18079/v1 Zhou S et al. AJR 2020; 215:1-8; doi.org/10.2214/AJR.20.22975 Li J et al. medRxiv preprint 2020; doi: https://doi. org/10.1101/2020.02.11.20022053 Deng SQ, Peng HJ. J. Clin. Med. 2020; 9, 575 (Review); doi:10.3390/jcm9020575 Ständiger Arbeitskreis der Kompetenz- und Behandlungszentren für Krankheiten durch hochpathogene Erreger am Robert Koch-Institut (STAKOB). Hinweise zu Erkennung, Diagnostik

15.

16.

17. 18.

19.

20.

21.

und Therapie von Patienten mit COVID-19; Downloaded 13. March 2020; www.rki.de/covid-19-therapie Chinese CoVID Management Guidelines-19, Version 7; published on 3/3/2020 by R.P.C. National Health Commission and the National Administration of Traditional Medicine of R.P.C.; translated by Jinwei Sun, Physician Specializing in Cardiovascular Disorders at the University of Milan-Bicocca Henry et al. 2020 Apr 10 Clinical Chemistry and Laboratory Medicine. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 PMID: 32286245 DOI: 10.1515/cclm2020-0369. Ferrari et al. 2020 Apr 16 Clinical Chemistry and Laboratory Medicine. Routine blood tests as a potential diagnostic tool for COVID-19 PMID: 3230176 DOI: 10.1515/cclm-2020-0398. Yuan et al. 2020 Mar 29 Inflammation Research. The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients PMID: 32227274 DOI: 10.1007/s00011-020-013242-0. Huang et al. 2020 Feb 15 The Lancet. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China PMID: 31986264 PMCID: PMC7159299 DOI: 10.1016/ S0140-6736(20) 30183-5. Chen et al. 2020 Feb 15 The Lancet. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study PMID: 32007143 PMCID: PMC7135076 DOI: 10.1016/S0140-6736(20)30211-7. The Governing Board The American Association for the Study of Liver Diseases, Released: April 7, 2020. CLINICAL IN

POINT OF CARE ©Abbott Point of Care Inc. 400 College Road East, Princeton, NJ 08540 (609) 454-9000 (609) 419-9370 (fax) www.pointofcare.abbott For in vitro diagnostic use only.

This material is intended for a U.S. audience only.

COVID-19 Channel Brochure - US 2994Rev.1 09/20 Piccolo Xpress is a registered trademark of Abaxis, Inc. and distributed by Abbott Point of Care. Abaxis 888-3354 Rev A

22.

23.

24.

25.

26.

27.

SIGHTS FOR HEPATOLOGY AND LIVER TRANSPLANT PROVIDERS DURING THE COVID-19 PANDEMIC. Zhou et al. 2020 Mar 28 The Lancet. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study PMID 32171076 DOI: 10.1016/S0140-6736(20) 30566-3. Guan et al. 2020 Apr 30 The New England Journal of Medicine. The Clinical Characteristics of Coronavirus Disease 2019 in China PMID: 32109013 PMCID: PMC7092819 DOI: 10.1056/NEJMoa2002032. Holshue et al and The Washington State 2019-nCoV Case Investigation Team 2020 Mar 5 The New England Journal of Medicine Case Reports. First Case of 2019 Novel Coronavirus in the United States PMID: 32004427 PMCID: PMC7092802 DOI: 10.1056/NEJMoa2001191. Wu et al. 2020 Mar 13 JAMA Internal Medicine. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China PMID: 32167524 PMCID: PMC7070509 DOI: 10.1001/jamainternmed.2020.0994. Chen et al. 2020 May 1 The Journal of Clinical Investigation. Clinical and immunological features of severe and moderate coronavirus disease 2019 PMID: 32217835 PMCID: PMC7190990 (available on 2020-08-01) DOI: 10.1172/ JCI137244. Wang et al. 2020 Apr 23 The Journal of Clinical Investigation Insight. The laboratory tests and host immunity of COVID-19 patients with different severity of illness PMID: 32324595 DOI: 10.1172/jci.insight.137799.

PRODUCT FOCUS

CHEMISTRY ANALYZERS

8909

Toxicology Screening Simplified Abbottâ€™s ImmTox 270 Benchtop Analyzer Now with 14 assays CLIA Categorized as Moderate Complexity From Abbott The ImmTox270 benchtop analyzer offers comprehensive toxicology screening solutions for physician offices, treatment centers and independent laboratories. Broad test menu with over 20 assays to choose from including 14 that are now available as moderately complex. With complete laboratory solutions from consultation to licensure, and compliance the Abbott Clinical Laboratory Solutions team has you covered.

View Brochures, Videos & More at POR.io Enter Number 8909 in the Search Area

PENTRA C400 CHEMISTRY ANALYZER

8910

From HORIBA Medical One benchtop, not a whole lab! No water system, drain or special electrical connected required to operate the Pentra C400 chemistry analyzer. Now you can have the power of a floor model analyzer on the benchtop! The Pentra C400 chemistry system processes up to 420 tests/hr including ISEs and offers routine metabolic assays, TDMs, DAUs and Adulterants, HbA1c and Vitamin D tests. With 40 open channels, you can add much more for a complete menu to meet your practice needs.

View Brochures, Videos & More at POR.io Enter Number 8910 in the Search Area

RX DAYTONA+ From Randox Laboratories The RX daytona+ is a fully automated, benchtop, clinical chemistry analyzer capable of performing high quality testing, with a combined throughput of 450 tests per hour, for accurate results you can trust. The most versatile analyzer in its class, the RX daytona+ combines robust hardware and intuitive software with the world leading RX series test menu for unrivaled performance, with direct HbA1c testing capabilities.

8911

14 | PHYSICIANS OFFICE RESOURCE

View Brochures, Videos & More at POR.io Enter Number 8911 in the Search Area

8912

Bionet CardioCare 2000: $1,255.00 Schiller AT-2 Plus: $2,626.00* 8913 *add Spirometry: $649.00 Burdick ELI 280: $4,088.00 Welch Allyn CP150 w/ Interp: $3,465.00

The Adview 2 is still the only truly modular diagnostic station that grows with your needs. Start with blood pressure and choose temperature or pulse oximetry option at the time of purchase.

8914 8915

8916

8917 8918

Coaxial Ophth, Fiber Optic Oto, Speucla Dispenser, Aneroid BP, Wall Transformer and Wall Board without Thermometer: $979.00 8919 with Thermometer: $1,416.00

8921

8920

8922

8923

CLIA WAIVED FULL COMPLEMENT OF CLIA-WAIVED

PRODUCT FOCUS

Full Complement of CLIA-waived Blood Chemistry Tests BLOOD CHEMISTRY TESTS PICCOLO ® Piccolo Xpress Chemistry Analyzer from Abbott

XPRESS® CHEMISTRY ANALYZER

The PiccoloFrom Xpress Chemistry Analyzer provides physician offices with Abbott lab-accurate results for a broad range of CLIA-waived general chemistry The Piccolo Xpress Chemistry Analyzer provides physician tests, including metabolic panels, lipids, and kidney function, offices with lab-accurate results liver, for a broad range of CLIA- and more with just 100waived microliters blood. Easy use, themetabolic Piccolo Xpress generalofchemistry tests,toincluding panels, provides lipids, live, and visit, kidneyaccelerating function, andtreatment more with decisions, just 100 results during a patient’s increasing microliters of blood. Easy to use, the PIccolo Xpress provides 8924 efficiency, and supporting patient satisfaction. Automated quality control on results during a patient’s visit, accelerating treatment decisions, every test helps ensure accuracy. increasing efficiency, and supporting patient satisfaction. Automated quality control on every test helps ensure accuracy. For in vitro diagnostic use only. This material is intended for a U.S. audience only. Piccolo Xpress is View a registered trademark of Abaxis, Inc. and by Abbott Point of Care. Brochures, Videos & distributed More at POR.io Physician Office Resource Piccolo Product Description – US 3065.REV1 08/20

Enter Number 8924 in the Search Area

LAB-ACCURATE RESULTS FOR ACR AND HBA1C

8925

From Abbott With its compact size and panel of tests, the Afinion 2 system is ideal for point-of-care testing in physician offices, clinics, community health centers and hospital out-patient clinics. From just a small urine or fingerstick whole blood sample, lab-accurate results for ACR and HbA1c are made available during the consultation.

View Brochures, Videos & More at POR.io Enter Number 8925 in the Search Area

8926

FIRST EVER CLIA WAIVED HEMATOLOGY ANALYZER From Sysmex Faster test results, clinical decisions and greater practice efficiency are coming to physicians’ offices with the first CLIA-waived CBC analyzer. Hematology diagnostics leader Sysmex is bringing more lab testing to the point of care. One of the most common blood tests can be conducted reliably and accurately on-site, in as few as three minutes. The device’s ease of use and innovative technology means in-house staff can operate it in just a few easy steps, without lengthy certification and training. The new Sysmex XW-100 will improve health care efficiency and patient care.

View Brochures, Videos & Mores at POR.io Enter Number 8926 in the Search Area

16 | PHYSICIANS OFFICE RESOURCE

8927

8928

8929

FEATURE

THE ROLE OF VITAMIN D IN THE COVID-19 PANDEMIC Growing evidence shows proper vitamin D levels help fight severity of illness, mortality rates. BY SEKISUI DIAGNOSTICS

When global scientists and researchers began sequencing the complete genome of SARS-CoV-2, the virus that causes COVID-19, they were racing to find treatment solutions for the novel coronavirus. Potential treatments were being investigated daily, including research of common vitamin sufficiency. Vitamin C and Zinc have long been known to boost immune system health, which could help against this respiratory illness. But how big could vitamin D’s role be in combating the effects of COVID-19? Somewhat surprisingly, researchers have discovered a strong correlation between severe vitamin D deficiency and mortality 18 | PHYSICIANS OFFICE RESOURCE

rates in COVID-19. Hospitals and clinics in China, France, Germany, Italy, Iran, South Korea, Spain, Switzerland, the United Kingdom and the United States have noted patients with lower levels of vitamin D had higher mortality rates than patients who were not deficient in vitamin D. Unexplained differences in COVID-19 mortality rates from country to country originally led researchers to examine vitamin D levels and cytokine storm – a hyperinflammatory condition caused by an overactive immune system – and a correlation between vitamin D deficiency and mortality. For example, patients from Italy, Spain and the United Kingdom

FEATURE

had lower levels of vitamin D compared to patients in other countries, and they also had higher mortality rates. Patients in Norway, Finland and Sweden had higher vitamin D levels despite less sunlight exposure than Italy and Spain because supplementation and fortification of foods is more common in these Nordic countries.

African Americans. Exposure to sunlight each day helps the human body to manufacture the required amount of vitamin D, but most people avoid sun exposure due to the fear of developing skin cancer. To prevent vitamin D deficiency, one should spend 15 to 20 minutes daily in the sunlight with 40% of the skin surface exposed.

The correlation between low vitamin D levels, cytokine storm and death from COVID-19 is statistically significant. Cytokine storm can severely damage lungs and lead to acute respiratory distress syndrome, and this is what seems to be the cause of most COVID-19 related deaths. However, vitamin D enhances the immune system and helps prevent the immune system from becoming dangerously overactive. It won’t prevent a patient from contracting COVID-19, but according to some recent studies, it might cut the mortality rate of COVID-19 in half and reduce complications. Researchers note that vitamin D deficiency is more prevalent in African American patients and elderly patients – two populations that have been most affected by COVID-19.

High concentration of melanin in the skin slows the production of vitamin D and aging greatly reduces skin production of vitamin D. The amount of vitamin D your skin makes also depends on the time of day, season and latitude. It may decrease or be completely absent during winter months, depending upon lifestyle.

How many people are vitamin D deficient? Vitamin D deficiency is very common as an estimated 1 billion people worldwide have low levels of vitamin D in their blood. About 42% of adults in the United States are deficient, and this percentage jumps to 69% in Hispanics and 82% in

Vitamin D supplementation To make it even more challenging, vitamin D isn’t found in many foods. However, it can be found in fortified milk, fortified cereal and fatty fish like salmon, mackerel and sardines. The recommended daily amount of vitamin D is 400 international units (IU) for children up to 12 months, 600 IU for ages 1 to 70, and 800 IU for ages over 70 years. Taking a multivitamin with vitamin D will likely help older adults who don’t get regular exposure to sunlight, have trouble absorbing vitamin D and are at higher risk for developing osteoporosis. Vitamin D is generally considered safe when taken in appropriate doses. 2021, ISSUE 1 | 19

PRODUCT FOCUS

CLIA WAIVED

8930

ULTRA HCG COMBO TEST From Sekisui Diagnostics The OSOM® Ultra hCG Combo test is a simple immunoassay for the qualitative detection of human chorionic gonadotropin (hCG) in serum or urine for the early confirmation of pregnancy. Internal studies have confirmed that the OSOM® Ultra hCG Combo test does not have a false negative result from hCG variants providing physicians with a higher level of confidence.

View Brochures, Videos & More at POR.io Enter Number 8930 in the Search Area

OSOM® ULTRA STREP A TEST

From Sekisui Diagnostics

8931

The OSOM® Ultra Strep A test is a color immunochromatographic assay intended for the qualitative detection of Group A Streptococcus antigen directly from throat swab specimens. Shown to be not statistically different than single swab culture. Sensitivity 95.7% and 100% Specificity. Includes two additional test sticks for External QC. CLIA Waived..

View Brochures, Videos & More at POR.io Enter Number 8931 in the Search Area

OSOM® TRICHOMONAS RAPID TEST From Sekisui Diagnostics

The OSOM® Trichomonas Rapid Test is intended for the qualitative detection of Trichomonas vaginalis antigens from vaginal swabs or from the saline solution. The OSOM® Trichomonas Rapid Test is the only CLIA-waived rapid test available today. OSOM® Trichomonas is more sensitive than wet mount due to the assay being able to detect viable and non-viable organisms which offers significant benefits to the patient and clinician alike.

8932

20 | PHYSICIANS OFFICE RESOURCE

View Brochures, Videos & More at POR.io Enter Number 8932 in the Search Area

TO X I C O LO G Y S C R E E N I N G

SIMPLIFIED Comprehensive toxicology menu now with 14 CLIA1 categorized moderately complex assays.

8933

IMMTOX™ 270 BENCHTOP ANALYZER Toxicology screening solutions for physician offices, treatment centers and laboratories. n

25 assay menu

Up to 270 tests per hour

Compact footprint

Quality products, service and reliability

COMPLETE LABORATORY SOLUTIONS From consultation, to licensure and compliance, the Abbott Clinical Lab Solutions team has you covered.

CONTACT ABBOTT CLINICAL LAB SOLUTIONS. CALL 888-831-6850 | EMAIL: CLS_SALES@ABBOTT.COM 1. Clinical Laboratory Improvement Amendments (CLIA) © 2020 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. Any photos displayed are for illustrative purposes only. MKT52247 REV1 08/20

COVID-19 TESTING PRODUCT FOCUS

BD VERITOR™ PLUS SYSTEM From BD Veritor™

8934

The BD Veritor™ Plus System is a portable, easy-to-use, testing solution for SARS-COV-2*, Flu A+ B and other respiratory tract infections that delivers results in 15 minutes or less. It features two analysis modes that adapt to your workflow, online education tools, and optional reporting capabilities including the BD Synapsys™ Informatics Solution—making it the point-ofcare diagnostic tool you won’t want to be without. *EUA authorized by FDA

View Brochures, Videos & More at POR.io Enter Number 8934 in the Search Area

BIOFIRE® RESPIRATORY 2.1-EZ (RP2.1-EZ)1 PANEL (EUA)1

From BioFire

SARS-CoV-2 is everyone’s top suspect, but many other respiratory bugs can cause similar, overlapping symptoms. In your clinic, you can test for 19 common respiratory pathogens, including SARS- CoV-2, with the BioFire RP2.1-EZ Panel (EUA)1—now available under an FDA Emergency Use Authorization. Syndromic testing means all it takes is one test and just 45 minutes to round up SARS-CoV-2—and all the other usual respiratory suspects.

8935

1. This test is not FDA cleared or approved. This test has been authorized by FDA under an EUA for use by authorized laboratories.

View Brochures, Videos & More at POR.io Enter Number 8935 in the Search Area

FIRST EUA POINT-OF-CARE (POC/WAIVED/ FINGERSTICK) COVID-19 ANTIBODY TEST NOW AVAILABLE From Carolina Liquid Chemistries

8936

The Fastep® COVID-19 IgG/IgM Rapid Test Device by Assure Tech., distributed in the USA by Carolina Liquid Chemistries, has received FDA Emergency Use Authorization for use with fingerstick whole blood specimens at the point-of-care, i.e. in patient care settings operating under CLIA Certificate of Waiver such as doctor’s offices, hospitals, urgent care centers and emergency rooms rather than having to be sent to a central lab.Refer to carolinachemistries.com for instructions for use, fact sheets, FDA EUA letters, clinical performance studies, and material safety data sheets. Not FDA cleared; only for emergency use under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless authorization is terminated or revoked.

View Brochures, Videos & More at POR.io Enter Number 8936 in the Search Area 22 | PHYSICIANS OFFICE RESOURCE

Solid & Glass Door Refrigerators From 1 to 15 Cu.ft.

Refrigerators & Freezers From 23 to 49 Cu.ft. Refrigeration designed and purpose-built for pharmacy, medication, and vaccination applications to support meeting CDC/VFC vaccine storage guidelines 8937

+/-1ºC variation derived from the maximum deviation of an NTC sensor in a 1 oz. vial located nearest the champer geometric center during a 24 hour test period

Advanced Temperature Control & Durable Performance

• Intelligent microprocessor digital temperature controller • Adjustable operating control range from +2 to +8ºC • Digital display of the min/max temperature in Celsius or Fahrenheit • Password protected control parameters beyond setpoitn • Optimized forced air cooling for excellent stability & uniformity with rapid recovery • Open door and high/low temperature alarms • Factory installed lock conveniently located towards the top of each unit • ��

Pharma-Vac Refrigerators Accucold ARS1PV ARG1PV ARS3PV ARG3PV ARS6PV ARG6PV ARS8PV ARG8PV ARS12PV ARG12PV ARS15PV ARG15PV

Capacity 1 cu.ft. 1 cu.ft. 3 cu.ft. 3 cu.ft. 6 cu.ft. 6 cu.ft. 8 cu.ft. 8 cu.ft. 12 cu.ft. 12 cu.ft. 15 cu.ft. 15 cu.ft.

Height 21.5” 21.5” 33.75” 33.75” 32.5” 32.5” 50” 50” 61.75” 61.75” 72” 72”

Width 17.5” 17.5” 18.5” 18.5” 23.5” 23.5” 23.38” 23.38” 23.38” 23.38” 23.5” 23.5”

Depth 19.5” 20” 19” 19.5” 24.5” 25” 24.5” 25” 24.5” 25” 24.5” 25”

Door White Glass White Glass White Glass White Glass White Glass White Glass

790*, 815.00 820.00 884.00 897.00 996.00 1,010.00 1,218.00 1,287.00 1,690.00 1,704.00 1,866.00 1,879.00

Height 83.75 83.75 83.75 83.75

Width 27.5 27.5 55.25 55.25

Depth 31 31 31 31

Door (1) Stainless (1) Glass (2) Stainless (2) Glass

790*, 2,311.00 2,633.00

Height 83.75 83.75

Width 27.5 55.25

Depth 31 31

Door (1) Stainless (2) Stainless

790*, 2,633.00 4,037.00

Pharma-Lab Refrigerators Accucold ARS23ML ARG23ML ARS49ML ARG49ML

Capacity 23 cu.ft. 23 cu.ft. 49 cu.ft. 49 cu.ft.

3 503 00 4,037.00

Pharma-Lab Freezers Accucold AFS23ML AFS49ML

Capacity 23 cu.ft. 49 cu.ft.

Choosing the Right Sized Unit Below are a few handy steps for determining the ideal Accucold refrigerator size for your clinic:

Estimate the maximum number of doses of publicly-provided vaccine and privately purchased vaccine that will be in your refrigerator.

Refrigerator: Public Vaccine

Add the number of doses on hand (current inventory) from your last order form. ________________

Match your maximum doses with the minimum cubic feet needed to safely store your vaccine

Max. Doses

Minimum Cubic Ft.

2,000+ doses

may need more than one refrigerator

1000-2000

40 cu.ft 36 cu.ft 21-23 cu.ft

Private Vaccine

+ ________________

900-1000 801-900

Total doses

= ________________

701-800

17-19.5 cu.ft

Multiply (max inventory) Maximum doses

x 1.25 = ________________

400-700

11-16.7 cu.ft

100-399

4.9-6.1 cu.ft

CRYOSURGERY CRYOLAB® MEDICAL From CryoConcepts CryoLab is a desk-top sized unit that delivers cryogen and employs pre-set spray times to ensure safe and effective treatment. Our lighted wand can spray the cryogen from any direction making it easier to treat all locations on the patient. CryoLab® can dispense nitrous oxide or carbon dioxide allowing physicians to treat cosmetically sensitive areas on the face, hands, and chest with less trauma and downtime. —

8938

View Brochures, Videos & More at POR.io Enter Number 8938 in the Search Area

HISTOFREEZER® FLEX From CryoConcepts This canister-based devices is the latest advance in portable cryosurgery for the physician office. Its advanced design give doctors the option of using cones or buds to deliver the cryogen to the treatment site. There is no risk of cryogen splattering during treatment and our cryogen stays colder versus other products on the market which lead to better first time outcomes.

8939

—

View Brochures, Videos & More at POR.io Enter Number 8939 in the Search Area

CRYOCLEAR® From CryoConcepts 8940

This is a new pen-like cryo devices that dispenses carbon dioxide which is perfect for superficial lesions such as sun spots, age spots, and shin tags. CryoClear® has enough gas to treat between 20 and 30 lesions depending on the size and type. —

View Brochures, Videos & More at POR.io Enter Number 8940 in the Search Area

24 | PHYSICIANS OFFICE RESOURCE

8941

SPIROMETRY PRODUCT FOCUS

SPIROMETRY IS EASY From MicroDirect

8942

Unless the equipment is easy to use, it will not be fully utilized by your staff. The MicroLab and MicroLoop are menu driven via a large graphic display and the test takes less than five minutes to perform. The easy-to-read reports, quality checks and built-in interpretation assist with your diagnosis. Your office sees patients with indications for spirometry on a daily basis. Accurately and quickly diagnosis them so you can properly treat them.

View Brochures, Videos & More at POR.io Enter Number 8942 in the Search Area

MICRO 1 SPIROMETER From MicroDirect Specifically designed for situations where low cost precision spirometry measurements are required, the Micro I Spirometer measures the following parameters FEV1, FVC, PEF, FEF25-75, EEV6, FEV1/FVC, FEV1/FEV6, FEF25 and FEF25 that cn be displayed along with percent predicted and post bronchodilator comparisons and provide an optional printout if needed. Extremely lightweight and portable making it suitable for hospital outreach clinics, bedside screenings, health fair screenings and other situations where remote testing is required.

8943

View Brochures, Videos & More at POR.io Enter Number 8943 in the Search Area

PORTABLE, SINGLE CLICK OPERATION SPIROMETER 8944

From MicroDirect The MicroDirect SpiroUSB many features include single click operation of all main functions, full ATS/ERS test quality checks, real time Flow/Volume and Volume/ Time traces, a choice of child incentive displays, choice of predicted values, estimated lung age, pre/post bronchodilator comparisons and can be used on multiple PCâ€™s with dongle software protection key. The child incentive display and ATS quality checks ensure maximal results every time. Use with a laptop for true portability.

View Brochures, Videos & More at POR.io Enter Number 8944 in the Search Area

26 | PHYSICIANS OFFICE RESOURCE

EXAM ROOM EQUIPMENT 8945

BREWER’S FLEX™ ACCESS EXAM TABLE From Brewer Step up to power table performance for less with Brewer’s Flex™ Access Exam Table. Industry-leading 700-lb. patient weight capacity, unique safety features and unmatched ergonomic patient access maximize your clinical efficiency and ROI. A streamlined footprint and optional upgrades like safety grab bars, stirrups, and pass-through work surface provide ultimate flexibility for your practice.

View Brochures, Videos & More at POR.io Enter Number 8945 in the Search Area

THE BREWER BASIC EXAM TABLE From Brewer

8946

Full featured, entry-level exam table design. The Brewer Basic Exam Table features a pneumatic cylinder, seamless upholstery, and the largest storage capacity available. We invite you to compare features, price, warranty and you will find the Brewer Basic Exam Table is clearly the best entry level exam table available.

View Brochures, Videos & More at POR.io Enter Number 8946 in the Search Area

8947

BREWER’S ACCESS™ HIGH-LOW EXAM TABLE From Brewer Design provides an 18” profile in the seated position to allow level transfer from standard wheelchair heights, complete with upright seat back and safety grab bars to simplify reliable patient transfers. The system also offers abundant storage capacity with Brewer’s signature pass-through drawer system and it is backed by Brewer’s standard 3-year warranty.

View Brochures, Videos & More at POR.io Enter Number 8947 in the Search Area

2021, ISSUE 1 | 27

FEATURE

PLANNING FOR NEW INSTRUMENTS AND TESTS BY IRWIN Z. ROTHENBERG, MBA, MS, CLS(ASCP),

TECHNICAL WRITER /QUALITY ADVISOR, COLA RESOURCES, INC.

Introduction Whether planning a new, start-up laboratory operation, or performing an analysis of current testing, (providing input for decisions on whether or not to purchase new or replacement instruments, or add or delete tests), it is important to do a realistic assessment not only of what you want to offer your ordering physicians, but what you can realistically offer. The laboratory’s test menu should be aligned as closely as possible with physician expectations and needs, as well as the laboratory’s operational capabilities. By strengthening relationships with ordering physicians, laboratories can more accurately forecast future service needs and make the best decisions as to test menu, instrumentation, and staffing, including which tests to outsource or maintain in-house. Begin this process by: Reviewing Basic Information about the Current / Proposed Laboratory Operation

28 | PHYSICIANS OFFICE RESOURCE

The first step in the planning process for adding new tests and new instrumentation begins with asking the following baseline questions regarding the present or proposed laboratory operation: • What is your present test menu? Present instrumentation? Present staffing levels? • What medical specialties are represented by your ordering physicians? (an important determinant of what tests will be requested, as well as patient demographics) • Do you anticipate changes in the number of client physicians served? New specialties added? New populations served? • What are your current or anticipated test volumes / demand for specific tests? • What is the complexity of testing already performed or planned? (waived vs. non-waived, with attendant regulatory requirements, including personnel)

FEATURE

• What are your present hours of operation with attendant staffing levels / type and volume of testing performed per shift / commitment for turn-around times? • What are your anticipated operating and capital budgets? (important determinant for changes to instrumentation and level of automation; as well as staffing expertise)

Determine the Feasibility of Adding New Tests: Perform a Cost / Benefit Analysis It is by taking into account the internal as well as external factors in the laboratory environment, that the decisions made will have the best chance of success. Below are items to consider for your cost/benefit analysis:

• Is adequate work space available to accommodate all phases of new patient testing from specimen collection to test result reporting? The answers to these questions provide guidance for any changes to the test menu, which will be a driver for decisions on whether to acquire new or replacement instruments.

• Instrument capacity for current or proposed test menu (is it “right-sized” for test volume and level of staffing)

The next step forward is to perform a Cost/Benefit analysis of your present operation, and of the proposed changes to the test systems to determine economic and logistical feasibility.

• Reagent life (expiration dates: days, weeks, months before/ after opening packages)

• Instrument cost (purchase or lease) • Reagent cost (are you obligated to purchase reagents from a particular manufacturer?)

2021, ISSUE 1 | 29

• Storage requirements for reagents (do you need to buy a new refrigerator or freezer?)

to determine market opportunity. These estimates will drive financial outcomes.

FEATURE

• Frequency and expense of Quality Controls, Calibration, and Maintenance

• If you are part of an organization that has adopted the concept of value-based medical care, and it now part of an Accountable Care Organization (ACO), or accepts “bun• Tests run singly or in batch-mode dled payments”, your expenses will come under increased pressure to be held down and minimized. You may be • Comparison of in-house testing with reference laboratory encouraged to outsource more than originally planned. charges and turn-around time • The well-documented staffing shortage may be a factor • Complexity of present and proposed testing. in your area; consider your local situation if planning to increase testing, add shifts, and new pre-analytic services. • Staffing requirements: number, training expenses; qualifications and experience beyond present staffing; Of course, providing the highest level of service for your continuing education patients may justify costs associated with the above considerations, but it is vital to ensure that your instrumentation • Proficiency Testing requirements can handle the changes in projected demand in terms of test volume capacity, variety of tests offered, operating • Facility space, ventilation, electrical needs; hazardous times and staffing. This may require considering more disposal requirements automation. Automation has long been regarded as an important means for clinical laboratories to achieve greater • Time and involvement of the Lab Director, and the operational efficiency, test accuracy, method standardiza Technical Consultant tion, total data handling and reduced turnaround time; in short, an improved quality of patient care. • Document storage requirements / LIS capability The development of new generations of automated standalone and bench top equipment has made automation a • Adjusting the front office staffing to handle additional pre more viable option for labs of all sizes—and in many cases, and post analytical paperwork and communications a necessary option for labs seeking to remain competitive in today’s marketplace. Additional strategies to determine the appropriateness of testing offered, and the instruSteps in Determining the Right Automation for mentation needed. Your Laboratory • Analyze test mix and outsource demanded but low-volume tests. Only outsource these tests if you can provide the test results a lower cost and with a better turnaround time. • Project test demand and costs to determine which tests to perform in house. Conversely, analysis of send-out volumes may indicate opportunities to bring certain tests in-house. • Partner with reference laboratories. Reference laboratories can provide valuable support in the form of financial analysis, methodology assessment, and provision of clinical samples to help make in-source-versus-outsource decisions and to establish and increase on-site test volumes. Consider external factors as well Consider what is going on in the laboratory industry today, noting trends both locally and across the country and seeing if these factors may affect your laboratory: • What will be the impact of changes in reimbursement / payment mechanisms? • What is the current market for your laboratory services? Estimating market size and location is a critical component 30 | PHYSICIANS OFFICE RESOURCE

A. Questions to ask when deciding how much automation is needed The amount of automation needed depends on the type and size of your laboratory. If all you are looking for is increased throughput and you don’t really have to deal with diverse assays and readouts, then you might want to think about modular components. So with a few nonintegrated pieces of equipment, you can get the throughput you need without a huge investment, or additional space required. B. Set priorities for automation based on realistic budget limitations Once you have taken care of the above, and determined your needs, start getting quotes on systems needed. Budget negotiations will begin, with sets of reality checks on what is doable and what is not. Decisions should be based on priorities set in advance. C. A few more points to remember Always choose a vendor who can provide prompt, affordable service to minimize any downtime. Remember the data management involved. There are different sets of tools for data processing, data mining and data visualization, and you need to think about how you are going to track and analyze this data. Finally, create an infrastructure that can

be easily modified or expanded for other applications. D. Plan for downtime for routine maintenance and equipment breakdown

Endnotes

E. Consider purchasing a service contract A service contract can include many services beyond a general warranty, such as software updates, calibration, certification, preventative maintenance, priority service, and/or additional discounts on upgrades. Service contracts can be costly, and you can either discuss options with colleagues or make your own informed decision. Several reasons why you may chose to purchase a service contract could include reduced hassles if your equipment breaks, faster/priority repairs and a predictable expense in your budget. If a piece of equipment is critical to your work, you use it frequently, and major repairs are very expensive, a service contract may be worthwhile. In terms of budget, you will know exactly what you are going to pay in advance and will not be blindsided with a major “surprise” expense.

1. R. Saunders and A. Westerink. Sidebar: The Strategic Value of laboratory Outreach. Nov 1, 2014. http:// www.hfma.org/Content.aspx?id=25853

Recognize the strategic importance of physician / laboratory relationships One of the ways that laboratories can use their resources more effectively is to strengthen their relationships with physicians. These relationships are vital as strategic assets, and, as the demands on physicians continue to multiply, they will increasingly rely on their laboratory partners for diagnostic support. Physicians increasingly seek a diagnostic resource that can meet all of their testing needs. Laboratories are discovering that they are well positioned to provide medical guidance and direction for clinicians who are trying to maneuver their way through the increasingly complex world of laboratory testing. To efficiently manage laboratory test utilization requires both ensuring adequate utilization of needed tests in some patients and discouraging superfluous tests in other patients. An important step in this process is to work with client physicians on a program of proper test utilization to encourage the most efficient and relevant use of the testing offered. The key role of competent management in accomplishing these goals Effective laboratory planning requires competent management It is through the application of management skills that you can implement change with minimal disruption. Competent laboratory management includes effective communication with the staff; providing key information and direction for the continuing future development of the laboratory; and encouraging involvement in the development of strategic plans. Successful management can motivate staff to provide feedback about their workload; instruments and kits used; make suggestions for improvement of, and changes to, their test menu; and provide information about interactions with other offices, departments, physicians, and patients. These types of information play an important role when developing strategies for cost containment, automation, growth, re-alignment, and even repositioning of the lab in the community.

2. The Cost Effective Laboratory: The Changing Landscape of Laboratory Testing. Laboratory Testing Matters. August 2015. http://www.labtestingmatters. org/the-cost-effective-laboratory-the-changing-landscape-of-laboratory-testing/ 3. R. Saunders and A. Westerink. Sidebar: The Strategic Value of laboratory Outreach. Nov 1, 2014. http:// www.hfma.org/Content.aspx?id=25853 4. Strategic Planning For The Clinical laboratory. Martha Robbins and Associates. Clinical laboratory Consulting. http://www.labconsultant.com/strategic.htm 5. G Tufel Right-Sizing Laboratory Automation. Clinical Lab Products. December 17, 2014. http://www.clpmag.com/2014/12/right-sizing-laboratory-automation/ 6. M. Ferrer. Ask the Expert: How to Automate Your Lab to Best Fit Your Needs. Lab Manager. January 2011. http://www.labmanager.com/ask-the-expert/2011/01/ ask-the-expert-how-to-automate-your-lab-to-best-fityour-needs 7. K Huey. Starting a New Lab: How to Develop a Budget and Buy Equipment. American Physiological Society (APS). http://www.the-aps.org/mm/Careers/Mentor/Managing-a-Lab-and-Personnel/Early-Career-Professionals/Setting-Up-a-Laboratory/Developing-a-Budget-and-Buying-Equipment 8. R. Saunders and A. Westerink. Sidebar: The Strategic Value of laboratory Outreach. Nov 1, 2014. http:// www.hfma.org/Content.aspx?id=25853 9. Dr. Curtis Hanson and Elizabeth Plumhoff. MAYO CLINIC: Test Utilization and the Clinical Laboratory. May 2012. http://www.mayomedicallaboratories.com/ articles/communique/2012/05.html 10. How To become A Good Lab Manager by Elizabeth Sandquist. ASBMB Today. October 2013.

FLU TESTING PRODUCT FOCUS

CLIA-WAIVED BIOFIRE® FILMARRAY® RESPIRATORY PANEL (RP) EZ 8948

From BioFire The BioFire RP EZ accurately detects and identifies 14 viral and bacterial pathogens—not just Flu A and Flu B—so you can provide your patients with the right treatment, the first time. The test is easy and can be performed right in your office or clinic, with results in about an hour. The BioFire RP EZ is designed to run on a single computer/instrument configuration (EZ Configuration) of the BioFire® FilmArray® 2.0 System.

—

View Brochures, Videos & More at POR.io Enter Number 8948 in the Search Area

BD VERITOR™ PLUS SYSTEM From BD Veritor™ The BD Veritor™ Plus System is a portable, easy-to-use, testing solution for SARS-COV-2*, Flu A+ B and other respiratory tract infections that delivers results in 15 minutes or less. It features two analysis modes that adapt to your workflow, online education tools, and optional reporting capabilities including the BD Synapsys™ Informatics Solution—making it the point-ofcare diagnostic tool you won’t want to be without.

8949

*EUA authorized by FDA

View Brochures, Videos & More at POR.io Enter Number 8949 in the Search Area

OSOM ULTRA PLUS FLU A&B TEST 8950

From Sekisui Stronger Clinical Performance Takes Lateral Flow Testing To The Next Level. Providing superior rapid results at the point-of-care. Fast, easy, cost effective so you can test and treat in one visit. • High Performance- Equivalent or exceeding the performance of reader devices, without the need for an instrument • Results in 10 minutes • OSOM® Custom Care- Exceptional Support/Training by licensed medical technologists and experienced healthcare professionals • Made in the USA —

View Brochures, Videos & More at POR.io Enter Number 8950 in the Search Area

32 | PHYSICIANS OFFICE RESOURCE

Why You Should Be Doing Spirometry

8951

8952 It’s Important - Spirometry is the gold standard for the diagnosis and management of both asthma and COPD. It’s Good Medicine - Your patients are correctly diagnosed and treated more accurately and conveniently in your office. The earlier you detect the disease; the easier you can treat it. It’s Easy - A spirometry test takes less than five minutes to perform. It’s Good Business - Office spirometry is third party reimbursable and will pay for itself within the first year of purchase. It’s Safe - The SpiroSafe filter is single use viral/bacterial filters that helps to protect your patients and staff. It is >99% effective against viral and bacterial cross-contamination. Why Micro Direct? - Micro Direct’s spirometry experts will help you choose the right spirometer and then FULLY support your staff from training on how to use the spirometer through billing questions; and all Micro Direct spirometers are backed by a 30-day money back guarantee.

Micro Direct, Inc. 803 Webster Street Lewiston, ME 04240 1-888-287-8556 sales@mdspiro.com

www.mdspiro.com

8953

PRODUCT FOCUS

HEMATOLOGY ANALYZERS PENTRA 60 C+ HEMATOLOGY ANALYZER WITH 5-PART DIFFERENTIAL

8954

From HORIBA Medical Now you can have the same results hospitals and reference labs provide in a small, benchtop analyzer. The Pentra 60 C+ hematology analyzer provides a CBC with 5-part differential result using proprietary technology that ensures an accurate count and differential on the first run. Reduce repeats and reflex to the microscope with Pentra hematology technology.

View Brochures, Videos & More at POR.io Enter Number 8954 in the Search Area

TURN SMALL PLACES INTO SMART SPACES From Abbott

8955

With reduced budgets, shrinking laboratory space and staffing challenges, many laboratories need a solution that lets them work smarter with less. The CELL-DYN Emerald 22 AL is a full performance, automated optical 5-part differential analyzer that delivers smarter results for small to midsize clinical laboratories. • Compact Design • Walkaway Functionality • Ease Of Use • Smart Safety Features

View Brochures, Videos & More at POR.io Enter Number 8955 in the Search Area

CELL-DYN EMERALD HEMATOLOGY ANALYZER From Abbott

8956

CELL-DYN Emerald is a 3-part differential hematology analyzer that offers high performance in an affordable, compact design that provides reliable and accurate patient results every time. As a smaller operating laboratory, you need a solution that offers reliable results. CELL-DYN Emerald provides results in under 65 seconds. CELL-DYN Emereald’s small size, simple touch screen software and reliability offer an easy-to-use, truly compact table/bench top instrument for easy performance in your laboratory.

View Brochures, Videos & More at POR.io Enter Number 8957 in the Search Area

34 | PHYSICIANS OFFICE RESOURCE

HEMATOLOGY ANALYZERS EASY, INTEGRATED WITH-PATIENT SYSTEM Easy, TESTING IntegratedI-STAT With-Patient Testing From Point of Care at Abbott i-STAT System from Point of Care at Abbott The handheld i-STAT System offers a broad menu of diagnostic tests

at the patient’s side inSystem just minutes. Witha just a few drops of of blood, The handheld i-STAT offers broad menu diagnostic tests at th the i-STAT System delivers real time, lab-accurate results for a wide patient’s side in just minutes. With just a few drops of blood, the i-STAT range of tests, including chemistries, blood gas, coagulation, cardiac markers, and more. delays and wasted time with System delivers real Minimize time, lab-accurate results foron-side a wide range of tests, tests. Easy, intuitive operation. including chemistries, blood gas, coagulation, cardiac markers, and more. 8957 For intended andwasted completetime product information, pointofMinimize delaysuse and with on-site visit tests. Easy, intuitive operatio care.abbott.

For intended use and complete product information, visit pointofcare.abbott. For in vitro diagnostic use only. This material is intended for a U.S.

For in vitro diagnostic usei-STAT only. This is intended for a U.S. audience only.Reaudience only. is amaterial trademark of Abbott. Physician Office i-STAT issource a trademark of Abbott. Physician Office—Resource i-STAT Product i-STAT Product Description US 3064.REV1 08/20 Description – US 3064.REV1 08/20

View Brochures, Videos & More at POR.io Enter Number 8957 in the Search Area

MICROS HEMATOLOGY ANALYZER WITH 3-PART DIFFERENTIAL PLUS THE LITEDM

8958

From HORIBA Medical Is it viral or bacterial? A CBC with 3-part differential can provide the clues to help distinguish between viral and bacterial infections before you decide to treat. The Micros 60 Hematology analyzer provides a CBC with 3-part Diff result in less than 60 seconds using only 10 µL of sample. Connect to the LiteDM Patient Data Management System for an affordable way to consolidate patient results to one report.

View Brochures, Videos & More at POR.io Enter Number 8959 in the Search Area

8959

MINÍÍMIZE THE HASSLE OF ESR TESTING IN YOUR LAB From ALCOR Scientific miniiSED™ is the newest of the iSED® family of ESR analyzers from ALCOR Scientific. The miniiSED™ measurement of ESR is accurate and unaffected by variables associated with traditional methodologies, such as hematocrit. This single position, fully automated ESR analyzer works directly from primary EDTA tubes, requires 100 μL of sample, has an internal barcode reader, and produces results in 15 seconds! miniiSED™ is the ideal solution to ESR testing for small laboratories, POL’s, and emergency clinics. Proudly manufactured in the USA.

View Brochures, Videos & More at POR.io Enter Number 8859 in the Search Area

2021, ISSUE 1 | 35

PRODUCT FOCUS

IMMUNOASSAY ANALYZERS FULLY AUTOMATED QUANTITIVE IMMUNOASSAY ANALYZER

8960

From Sekisui Diagnostics The FastPack® IP System is a fully automated quantitative immunoassay analyzer designed for use in the Physician Office laboratory. Utilizing sophisticated chemiluminescence technology, the FastPack® IP System provides the capability to produce complex immunoassay results in 12 minutes or less with a push of a button. Menu includes Vitamin D, Testosterone, TSH, Free T4 PSA and hCG.

View Brochures, Videos & More at POR.io Enter Number 8960 in the Search Area

LABORATORY SERVICES MEDICUS LIS From Medicus LIS

8961

If you are considering in-house lab testing, including Covid-19 testing and required reporting to state agencies, connecting Lab to LIS and EHR makes the process of test orders to completed results much easier. Providers receive test results posted to patient charts in real-time, expediting patient care, saving time, money and even preparing for lab test reimbursement goals. Link Your Lab with Medicus LIS today! Contact us: 888-643-8081 sales@medicuslis.com —

View Brochures, Videos & More at POR.io Enter Number 8961 in the Search Area

MAKE LABORATORY COMPLIANCE AND INSPECTION EASIER From My Inspection Make laboratory compliance and inspections easier by changing how you document, save and retrieve all information necessary to meet CLIA and accreditation regulations. With two unique electronic tools My Compliance Manual and MyInspection™ Software, the guesswork and tedious task of interpreting and documenting policy, procedure, forms, charts and logs is over. Your lab will be compliant, have less paper, and be inspection ready.

8962

36 | PHYSICIANS OFFICE RESOURCE

View Brochures, Videos & More at POR.io Enter Number 8962 in the Search Area

8963

™

MINIIMIZE THE HASSLE OF ESR TESTING IN YOUR LAB The miniiSED™ requires just 100µL of sample to provide fast, accurate, and reliable ESR results in just 15 seconds!

2021, ISSUE 1 | 37

PRODUCT FOCUS

TELEMEDICINE OPTIMIZE PRODUCTIVITY AND EXPAND YOUR PRACTICE From MedPod

8964

The Medpod Medical Cart optimizes productivity and load balancing by enabling access to remote physicians during high volume periods or to reach low-density populations. Medpod’s proprietary software integrates with a wide range of professional medical devices and gives the remote provider control of the devices to conduct an examination that is on par with a faceto-face visit. Patient images, audio and data can be captured, annotated, tagged and uploaded in real-time or stored and forwarded into the EHR by either remote or local provider.

View Brochures, Videos & More at POR.io Enter Number 8964 in the Search Area

DEFINING MOBILE TELEDIAGNOSTICS From MedPod With the ability to deploy into a medical ofﬁce in less than 2 minutes, MobileDoc is the ultimate portable practice. Revolutionary in its compact and mobile design, MobileDoc integrates best-in-class professional medical-grade devices with state-of-the-art HD video and EHR connectivity. Physicians can provide care remotely that is on par or better than a face-to-face visit, including conducting basic exams, checking vitals, and performing specialty testing— shattering the boundaries of traditional care.

8965

View Brochures, Videos & More at POR.io Enter Number 8965 in the Search Area

COMPLETE HOME BLOOD PRESSURE MONITORING PLATFORM From BPCorrect

8966

Designed by primary care doctors, BPCorrect is a complete home blood pressure monitoring platform consisting of a patient app and clinician portal. While many apps help patients track and display their BP, BPCorrect is the only app that guides patients through a scientific approach to accurately measure BP in the safety and privacy of their homes. BPCorrect works with affordable, validated BP monitors from well-known manufacturers. The web-based clinician portal, available in fall 2020, securely receives patients’ readings, summarizes these for providers and clinical staff members, and facilitates billing for remote monitoring. Please visit www.bpcorrect.com for more info.

View Brochures, Videos & More at POR.io Enter Number 8966 in the Search Area 38 | PHYSICIANS OFFICE RESOURCE

POINT OF CARE

EHENS PR I M

8967

TRANSFORM PATIENT SATISFACTION AND PRACTICE EFFICIENCY.

AVA I L A

CLIA Waived Tests: CMP, BMP, Lipid Panel, Lipid Panel Plus, General Chemistry, Kidney Check, Renal Panel, MetLyte 8 and Electrolytes

8968

Fast—Results in minutes, accelerating patient care decisions. Accurate—Lab-accurate results for a wide range of tests.* Versatile—Comprehensive CLIA-waived menu available. Simple—Intuitive function to improve operational efficiency. Convenient—Have test results during office visit, increasing patient satisfaction.

To learn more, contact your Abbott Point of Care representative at 888-893-0335, your distribution representative, or visit www.pointofcare.abbott *2016 Proficiency Testing Results, American Proficiency Institute, www.api-pt.com [Piccolo Xpress]. See cartridge information at www.pointofcare.abbott [i-STAT]. i-STAT Part No: 04J60-20 Waived Kit, 04J48-50 Moderately Complex Kit, 06F20-20 Waived Analyzer, 04P75-03 Moderately Complex Analyzer Piccolo Xpress Part No: 07P05-50 Piccolo Xpress with 3YR Serv, 07P05-51 Piccolo Xpress with 5YR Serv ©Abbott Point of Care Inc. 400 College Road East, Princeton, NJ 08540 www.pointofcare.abbott For in vitro diagnostic use only. This material is intended for a U.S. audience only. i-STAT is a trademark of Abbott. 3032.REV1 07/20 POR Ad - Abbott POC i-Stat/Piccolo Piccolo Xpress is a registered trademark of Abaxis, Inc. and distributed by Abbott Point of Care. Abaxis 888-3355 Rev A

FAST AND EASY. ACCURATE RESULTS EVERY TIME. CELL-DYN EMERALD Compact, easy-to-use 3-part differential hematology analyzer provides you with proven methods and technology, including electronic impedance, absorption spectrophotometry, electronic valves, cyanide-free lyse reagent, LCD color touch screen and USB ports. C O M PAC T D E S I G N Conserving valuable laboratory workspace with a small footprint and only 2 reagents plus on-board cleaner.

EASE OF USE • Decreasing manual entry errors and increasing compliance by use of barcoded reagents • Reducing hands-on time with touch-free scheduled daily maintenance, startup and shutdown

F L E X I B L E U S E R I N T E R FAC E • Improving use and easing training of software functions with color touch screen and numeric keypad • Providing positive patient identification with barcode reader for specimens

RELIABILIT Y Helping you keep your commitments

O P T I C A L 3-PA R T D I F F E R E N T I A L Delivering comprehensive results for your doctors and patients

Learn how the CELL-DYN Emerald 22 can help your laboratory operate more efficiently at:

COREL ABORATORY.ABBOT T/HEMATOLOGY

8969

For in vitro diagnostic only. Refer to the Operator’s Manual for operational precautions, limitations, and hazards. ADD-00074091 12/20.